| PharmaSUG |
2026 |
An Agentic AI Framework That Reads Statistical Analysis Plans and Generates TFL Table of Contents |
Siqi Wang, Toshio Kimura, Songgu Xie, Weiming Du |
source |
6 |
| PharmaSUG |
2026 |
Oncology Solid Tumor Subcutaneous vs Intravenous Late-stage Study Analysis |
Sumanjali Mangalarapu, Chuqing Chen, Anilkumar Anksapur |
source |
11 |
| PHUSE US |
2026 |
AI Reading and Understanding the SAP to Generate the TFL TOC |
Siqi Wang, Toshio Kimura |
source presentation source |
6 |
| PHUSE US |
2026 |
Prompt Engineering in Gen AI: A Game Changer for the professional development of Statistical Programmers and Data Scientists |
Kevin Lee |
source presentation source |
8 |
| PHUSE APAC |
2026 |
Crafting a recipe for success : Aligning Target Product Profiles and study design to ensure statistical significance translates to clinical relevance and role of DGF |
Soumitra Kar, Novo Nordisk GBS |
source presentation source |
9 |
| PHUSE APAC |
2026 |
Development of Statistical Scientists for Pharmaceutical Drug Development at India Global Capability Centres |
Suresh Chenji |
source presentation source |
6 |
| PharmaSUG |
2025 |
A Novel ADEFF Design with Varying Baseline Type Selections |
Tingting Tian, Chao Su, Fan Wang, Pengfei Zhu |
source |
6 |
| PharmaSUG |
2025 |
AI is coming for you: New Biometric Leadership in the era of Gen AI |
Kevin Lee |
source |
7 |
| PharmaSUG |
2025 |
Generative AI in Biometrics: Transforming Clinical Trials with Supercharged Efficiency an Innovation |
Kevin Lee |
source |
6 |
| PharmaSUG |
2025 |
Guidance from the FDA authored "Submitting Patient-Reported Outcome Data in Cancer Clinical Trials" and recommendations for their implementation in study CDISC COA data. |
Charity Quick |
source |
14 |
| PHUSE US |
2025 |
Efficient TFL Review within Statistical Programming - Using R and SAS |
Siddharth Kumar |
source presentation source |
8 |
| PHUSE US |
2025 |
eProtocol and the Promise of Automation |
Bill Qubeck, Suhas Giriraj |
source presentation source |
17 |
| PHUSE US |
2025 |
Revolutionising Clinical Trials: Gen AI-Powered Biometrics Breakthroughs |
Kevin Lee |
source presentation source |
6 |
| PHUSE EU |
2024 |
Quality Tolerance Limits: Understanding the added value and statistical need of implementing QTLs to assure subject safety and data quality |
Nathalie van Borrendam |
source presentation source |
3 |
| PHUSE EU |
2024 |
Strategies to Improve Understanding of Estimands and Analysis Section of Statistical Analysis Plan |
Inderjeet Arora |
source presentation source |
8 |
| PHUSE EU |
2022 |
Performance Traps in Multiple Imputation Analysis Using Mixed Model Repeated Measures [presentation] |
Piotr Karasiewicz |
source video |
17 |
| PharmaSUG |
2022 |
FDA Advisory Committee Meetings - A Statistical Programmer's Survival Guide |
Phil Hall |
source |
8 |
| PHUSE US |
2022 |
The Complexity and Magnitude of Participant Reactogenicity Data [presentation] |
Gunasekaran Subramaniam, Katrien Van der Donck |
source video |
21 |
| PHUSE US |
2021 |
Standing Room Only Presentation: DV10: Topline Results Dashboards with Rmarkdown & Flexdashboard [presentation] |
Harsha Kalikivayi, Robert Adams |
source |
26 |
| PharmaSUG |
2021 |
GCIG Criteria, Programming Makes It Easy |
Liming Xie, Wei Wei |
source |
9 |
| PHUSE EU |
2020 |
Using R Shiny to Increase the Efficiency of a Study Team [presentation] |
Emma Moore |
source video |
12 |
| PHUSE US |
2020 |
Design and Conduct of Clinical Trials: Past Present and Future. New Innovative Technology Methods |
George Obsekov |
source presentation source |
12 |
| PHUSE US |
2019 |
Dashboarding Analytics for Oncology Endpoint Data Using SAS |
Vidya Muthukumar |
source presentation source |
7 |
| PHUSE US |
2019 |
Striking a Balance: Adoption of Analysis Results Metadata (ARM) in Early Development Studies |
Janet Low, Pranab K. Mitra |
source presentation source |
6 |
| PharmaSUG |
2016 |
Programming checks: Reviewing the overall quality of the deliverables without parallel programming |
Shailendra Phadke, Veronika Csom |
source |
8 |
| PharmaSUG CN |
2015 |
Summary level clinical site data for data integrity review and inspection planning in NDA and BLA submission [presentation] |
Jingwei Gao, Nancy Bauer |
|
41 |
| PHUSE EU |
2012 |
To EC or Not EC...that is the Question! |
Hiren Naygandhi |
source presentation source |
8 |
| PharmaSUG |
2010 |
The Compliance and Implementation of Clinical Trial Outcome Disclosure on ClinicalTrials.gov |
Eric T. Sun, Craig Anderson |
|
13 |
| PHUSE EU |
2009 |
ClinicalTrials.gov - a programmers perspective |
Ralf Minkenberg |
source presentation source |
6 |
| SUGI |
1992 |
The Use of SAS/GRAPH Software in the Management of Clinical Trials |
MaryAnne DePesquo Hope |
source |
6 |